The Liver in Sickle Cell Disease

Clin Liver Dis. 2019 May;23(2):177-189. doi: 10.1016/j.cld.2018.12.002. Epub 2019 Feb 21.

Abstract

Patients with sickle cell disease can develop liver disease as a result of intrahepatic sickling of erythrocytes, viral hepatitis and iron overload secondary to multiple blood transfusions, and gallstone disease as a result of chronic hemolysis. The spectrum of clinical liver disease is wide and often multifactorial. Some patients develop cirrhosis that may progress to end-stage liver failure. Limited evidence exists for medical treatments. Exchange blood transfusions may improve outcomes in the acute liver syndromes. Liver transplantation may be an option for chronic liver disease. The role for prophylactic cholecystectomy in preventing complications of gallstone disease is controversial.

Keywords: Cholelithiasis; Intrahepatic cholestasis; Iron overload; Sickle cell hepatopathy; Sickle hepatic crisis; Viral hepatitis.

Publication types

  • Review

MeSH terms

  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / therapy
  • Blood Transfusion
  • Cholelithiasis / etiology*
  • Cholestasis, Intrahepatic / etiology
  • Hemolysis
  • Hepatitis, Viral, Human / etiology
  • Humans
  • Iron Overload / etiology
  • Liver Cirrhosis / etiology
  • Liver Diseases / etiology*
  • Liver Diseases / therapy
  • Transfusion Reaction / complications*